 treatment advanc neuroblastoma meta-iodobenzylguanidin februari decemb children advanc neuroblastoma meta-iodobenzylguanidin thirteen children resist first-lin therapi local relaps fourteen dissemin relaps bone marrow infiltr child resist first-lin therapi local relaps total cours dose gbq median gbq child cours cours cours cours cours common toxic effect thrombocytopenia platelet level evalu cours leukocyt count major respons complet month minor respons month respons children lesion residu primari tumor children relaps further studi role meta-iodobenzylguanidin treatment neuroblastoma